Evidence map›Paper›PMID 36597968›Full record

Observational studyRMD open2022

Association between HLA-B27 and peripheral spondyloarthritis phenotype: results from the ASAS perSpA study.

Marta Arevalo Salaet, Clementina López-Medina, Mireia Moreno, Victoria Navarro-Compan, Joan Calvet Fontova, Maria Llop, Maxime Dougados, Jordi Gratacós

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in RMD open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Uveitis in Psoriatic Arthritis: A Comprehensive Review.European journal of rheumatology · 2025
    Article
  7. Article
  8. Observational
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Marta Arevalo SalaetRheumatology, Consorcio Corporacion Sanitaria Parc Tauli, Sabadell, Spain.ORCID 0000-0002-1863-7494
Clementina López-MedinaRheumatology, Reina Sofia University Hospital, Cordoba, Spain.ORCID 0000-0002-2309-5837
Mireia MorenoRheumatology, Consorcio Corporacion Sanitaria Parc Tauli, Sabadell, Spain mmorenoma@gmail.com.ORCID 0000-0002-4365-4341
Victoria Navarro-CompanRheumatology, La Paz University Hospital, Madrid, Spain.
Joan Calvet FontovaRheumatology, Consorcio Corporacion Sanitaria Parc Tauli, Sabadell, Spain.
Maria LlopRheumatology, Consorcio Corporacion Sanitaria Parc Tauli, Sabadell, Spain.
Maxime DougadosHopital Cochin, Rheumatology, Université Paris Descartes Faculté de Médecine, Paris, France.ORCID 0000-0003-3009-6229
Jordi GratacósRheumatology, Consorcio Corporacion Sanitaria Parc Tauli, Sabadell, Spain.
Universitat Autònoma de Barcelona · ESInserm · FRHospital Universitario La Paz · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyse the influence of HLA-B27 in the phenotypical expression of peripheral spondyloarthritis (pSpA).

methodThis is an observational cross-sectional study using data from the Assessment of SpondyloArthritis international Society perSpA registry, including all patients with an available HLA-B27 test result and with a diagnosis of pSpA or psoriatic arthritis (PsA) as per rheumatologist's judgement. Demographic and clinical data, presence of extra musculoskeletal manifestations (EMM) and fibromyalgia were the variables included in a simple and multiple logistic regression model to assess their association to HLA-B27 positivity.

resultsFrom the 4465 patients included in the registry, 790 were classified as having either pSpA or PsA and had the HLA-B27 typing available. HLA-B27-positive patients presented a male predominance, had an earlier disease onset and a shorter diagnostic delay compared with the negatives. HLA-B27-positive patients presented a higher frequency of axial involvement, radiographic sacroiliitis, enthesitis and uveitis. Also, root joint involvement, poliarticular joint patern and tarsitis were significantly higher within HLA-B27-positive patients. Furthermore, we did not observe any association between the presence of HLA-B27 and peripheral joint damage, dactylitis, other EMM (psoriasis, inflammatory bowel disease) or fibromyalgia.The multivariable analysis confirmed the independent association of HLA-B27 positivity with male sex, an earlier onset of the disease, the presence of axial involvement, tarsitis and uveitis. SUMMARY: In summary, the presence of HLA-B27 in pSpA patients was associated with earlier disease onset and higher axial involvement, tarsitis and uveitis, but not with other EMM, fibromyalgia or peripheral structural damage.

Indexed as

Arthritis, PsoriaticFibromyalgiaSpondylarthritisUveitisCross-Sectional StudiesDelayed DiagnosisFemaleHLA-B27 AntigenHumansMalePhenotypeHLA-B27 AntigenArthritisSpondylitis, AnkylosingSynovitis

Identifiers

PMID36597968
PMCPMC9743377
OpenAlexW4310920002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.